<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00822471</url>
  </required_header>
  <id_info>
    <org_study_id>2002-288</org_study_id>
    <nct_id>NCT00822471</nct_id>
  </id_info>
  <brief_title>Feasibility and Impact of &quot;ABCs of Diabetes&quot; Self-Management Education Program at an Urban Public Library</brief_title>
  <official_title>Feasibility and Impact of of &quot;ABC's of Diabetes&quot; Self Management Education (DSME) Program for African Americans at an Urban Public Library on A1C, Lipid Lowering Agent Prescriptions and Emergency Department Visits</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medstar Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medstar Diabetes Institute;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>American Diabetes Association</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>CareFirst BlueCross Blue Shield;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>District of Columbia, Department of Health Block Grants Program;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Charles and Mary Latham Trust Fund;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hewlett-Packard</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Meltzer Entities;</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NBC Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Novo Nordisk A/S</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aventis Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Takeda Pharmaceuticals North America, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medstar Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A concise diabetes self-management education (DSME) program on the &quot;ABCs of Diabetes&quot; will be&#xD;
      placed in an urban public library to assess the feasibility of using this community setting&#xD;
      for the delivery of health care education in an urban African American population. Impact on&#xD;
      knowledge of, prescriptions for, and control of blood sugar (A1C), blood pressure (BP) and&#xD;
      LDL cholesterol (LDL-C)before and after participation in the program will be assessed. We&#xD;
      will also examine the frequency of emergency department (ED) visits and hospitalizations for&#xD;
      uncontrolled diabetes at 6 months post-DSME intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A free, community-based Diabetes Learning Center was placed in a public library. Adults with&#xD;
      diabetes (N=360) consented to participate in this prospective cohort study with historic&#xD;
      self-controls. The small group, interactive DSME (two 2-1/2 hour classes) focused on&#xD;
      improving CVD risk factors and enabling communication with the primary care physician.&#xD;
      Knowledge, prescriptions, diabetes-related testing and clinical outcomes were assessed.&#xD;
&#xD;
      &quot;ABCs of Diabetes&quot; DSME Program&#xD;
&#xD;
      Class #1: A1C, Aspirin &amp; Blood Pressure&#xD;
&#xD;
      A. Curriculum Content Areas:&#xD;
&#xD;
        -  What is diabetes?&#xD;
&#xD;
        -  A1C and blood glucose targets&#xD;
&#xD;
        -  Diabetes medications&#xD;
&#xD;
        -  Hypoglycemia&#xD;
&#xD;
        -  Managing Blood Pressure&#xD;
&#xD;
        -  Taking your medications&#xD;
&#xD;
        -  Preventing vascular complications&#xD;
&#xD;
        -  Monitoring your diabetes health&#xD;
&#xD;
        -  &quot;How to Talk to your Doctor&quot;&#xD;
&#xD;
      B. Education strategies &amp; tools&#xD;
&#xD;
        -  Role playing from &quot;How To Talk to Your Doctor&quot;&#xD;
&#xD;
        -  Ask for test results and how to get to targets&#xD;
&#xD;
        -  Prompts to schedule appointments for ADA recommended exams, tests and discuss diabetes&#xD;
           with primary care provider&#xD;
&#xD;
      Class #2 Cholesterol and Meal Planning&#xD;
&#xD;
      A. Curriculum Content Areas:&#xD;
&#xD;
        -  Managing cholesterol&#xD;
&#xD;
        -  Diet, exercise &amp; weight management&#xD;
&#xD;
        -  Cholesterol medications&#xD;
&#xD;
        -  Smoking cessation&#xD;
&#xD;
        -  Family Meal Planning:&#xD;
&#xD;
      consistent carbohydrate&#xD;
&#xD;
        -  heart healthy meals&#xD;
&#xD;
      B. Education strategies &amp; tools&#xD;
&#xD;
        -  View &quot;Cut the Fat Back&quot; video†&#xD;
&#xD;
        -  Interactive portion size &amp; meal planning strategies&#xD;
&#xD;
        -  Prompts to query PCP for LDL-C results;&#xD;
&#xD;
        -  Flyers with questions to focus PCP on ADA goals † Produced by the Health Promotion&#xD;
           Council, Philadelphia PA hpcpa@phmc.org&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">July 2005</completion_date>
  <primary_completion_date type="Actual">January 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvement in the percent of subjects correctly identifying guideline-recommended treatment targets for the &quot;ABC's of Diabetes&quot;, where A = A1C &lt; 7%; B = BP &lt;130/80mmHg and; and C = LDL-C &lt; 100mg/dl.</measure>
    <time_frame>6 months following program completion</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>increase the percentage of subjects taking medications for A1C, BP and LDL-C management and aspirin;</measure>
    <time_frame>6 months following DSME program completion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>increase scores on the diabetes self-efficacy scale (DES);</measure>
    <time_frame>6 months following DSME program completion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>increase percentage of patients with A1C, BP and LDL-C at recommended targets;</measure>
    <time_frame>6 months following program completion</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Decrease the percentage of participants with self-reported ED visits and hospitalizations for severe hypoglycemia and hyperglycemia.</measure>
    <time_frame>6 months following DSME program completion</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Diabetes</condition>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Diabetes Self-Management Education</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Education intervention with historic self-controls.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diabetes Self-Management Education</intervention_name>
    <description>DSME intervention consisting of two interactive 2-1/2 hour classes taught by a diabetes educator focusing on the &quot;ABCs of diabetes&quot; and training in how to talk to your doctor.</description>
    <arm_group_label>Diabetes Self-Management Education</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Diagnosis of Diabetes Mellitus, type 1 or type 2 for at least one month prior to&#xD;
             taking the first educational class.&#xD;
&#xD;
          2. 18 years old or older.&#xD;
&#xD;
          3. Females and Males&#xD;
&#xD;
          4. All ethnic groups.&#xD;
&#xD;
          5. Must be able to read and speak English.&#xD;
&#xD;
          6. Must be willing to sign informed consent to participate in the research component of&#xD;
             the program.&#xD;
&#xD;
          7. Plan on living in the District of Columbia for the next 6 to 8 months.&#xD;
&#xD;
          8. Willing to attend 2 core interactive education sessions within a 6-week period.&#xD;
&#xD;
          9. Willing to have a fingerstick performed to obtain blood for A1C and cholesterol&#xD;
             determinations prior to and 6 months after completion of the educational sessions.&#xD;
&#xD;
         10. Willing to attend both a pre- and a post-study outcomes data collection visit, each of&#xD;
             which will last approximately 1 - 1 ½ hours.&#xD;
&#xD;
         11. Ability and willingness to adhere to all study requirements.&#xD;
&#xD;
         12. Participant must have active health insurance coverage or self pay and have regular&#xD;
             visits to their primary care physician. Interested parties who do not have health&#xD;
             insurance will be referred to DHHS for assistance in applying for Medicare or Medicaid&#xD;
             when applicable.&#xD;
&#xD;
         13. Have access to telephone in residence to receive reminder calls for up upcoming&#xD;
             visits.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnancy.&#xD;
&#xD;
          2. Non-English speaking.&#xD;
&#xD;
          3. Untreated mental illness.&#xD;
&#xD;
          4. History of substance abuse or alcohol abuse in the past 12 months.&#xD;
&#xD;
          5. Individuals participating in a drug research study.&#xD;
&#xD;
          6. Presence of concomitant condition or circumstances which, in the opinion of the&#xD;
             investigator, could interfere with participation in the study, glycemic control or&#xD;
             interpretation of the data collected. (e.g. active malignance; HIV/AIDS)&#xD;
&#xD;
          7. Chronic concomitant use of oral steroids.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michelle F. Magee, MD, LRCPSI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medstar Health Research Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>January 12, 2009</study_first_submitted>
  <study_first_submitted_qc>January 13, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 14, 2009</study_first_posted>
  <last_update_submitted>August 21, 2020</last_update_submitted>
  <last_update_submitted_qc>August 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medstar Health Research Institute</investigator_affiliation>
    <investigator_full_name>Michelle Magee</investigator_full_name>
    <investigator_title>Professor of Medicine, Georgetown University School of Medicine</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Self-Management Education</keyword>
  <keyword>Library</keyword>
  <keyword>Emergency Department Visits</keyword>
  <keyword>African American</keyword>
  <keyword>CVD prevention</keyword>
  <keyword>Prevention</keyword>
  <keyword>Uncontrolled diabetes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

